Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eyepoint Pharmaceuticals Inc
(NQ:
EYPT
)
8.630
+0.260 (+3.11%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eyepoint Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
Next >
5 Analysts Have This to Say About EyePoint Pharmaceuticals
December 05, 2023
Via
Benzinga
Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 05, 2023
Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results.
Via
Benzinga
NIO Reports Q3 Results, Joins Hovnanian Enterprises, Signet Jewelers And Other Big Stocks Moving Higher On Tuesday
December 05, 2023
U.S. stocks traded mostly lower, with the Dow Jones index falling more than 100 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Expert Ratings for EyePoint Pharmaceuticals
November 02, 2023
Via
Benzinga
Where EyePoint Pharmaceuticals Stands With Analysts
July 28, 2023
Via
Benzinga
What 6 Analyst Ratings Have To Say About EyePoint Pharmaceuticals
June 28, 2023
Via
Benzinga
5 Analysts Have This to Say About EyePoint Pharmaceuticals
June 06, 2023
Via
Benzinga
Top 5 Health Care Stocks That Are Ticking Portfolio Bombs
December 05, 2023
As of Dec. 5, 2023, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Via
Benzinga
EyePoint Pharmaceuticals, Hut 8 Mining, GitLab, Take-Two Interactive, Tesla: Why These 5 Stocks Are On Investors' Radars Today
December 04, 2023
U.S. stocks experienced a downturn on Monday, with significant indices reflecting a bearish trend. The Dow slightly dipped by 0.11% to 36,204.44.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Crude Oil Falls Over 1%; EyePoint Pharmaceuticals Shares Spike Higher
December 04, 2023
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling around 150 points on Monday. The Dow traded down 0.17% to 36,182.82 while the NASDAQ fell 1.05% to 14,154.41. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
December 04, 2023
Via
Benzinga
Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session
December 04, 2023
Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the company announced pricing of registered follow-on offering of 10 million units at a purchase price of $1.20...
Via
Benzinga
Gold Down Over 2%; US Factory Orders Fall In October
December 04, 2023
U.S. stocks traded lower midway through trading, with the Dow Jones index falling over 100 points on Monday. The Dow traded down 0.36% to 36,116.18 while the NASDAQ fell 1.19% to 14,134.99. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is EyePoint Pharmaceuticals (EYPT) Stock Up 187% Today?
December 04, 2023
EyePoint Pharmaceuticals stock is rising higher with heavy trading of EYPT on Monday after posting positive results from a clinical trial.
Via
InvestorPlace
Nasdaq Down Over 100 Points; Alaska Air To Acquire Hawaiian Airlines
December 04, 2023
U.S. stocks traded lower this morning, with the Nasdaq Composite falling over 100 points on Monday. Following the market opening Monday, the Dow traded down 0.13% to 36,198.88 while the NASDAQ fell...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Age-Related Blindness Focused EyePoint Pharmaceuticals Stock Trading Over 300% Today?
December 04, 2023
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) announced topline results of its Phase 2 DAVIO 2 trial of EYP-1901, an investigational sustained delivery maintenance treatment for wet age-related macular...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 04, 2023
Via
Benzinga
Small Stakes, Big Rewards: 3 Penny Stocks with 300% Upside Potential
December 03, 2023
Although even so-called penny stocks with potential carry dramatic risks, these four-baggers benefit from analyst backing.
Via
InvestorPlace
Mizuho's Top Stock Picks For November Revealed
November 05, 2023
As trading for November begins, Mizuho recommends a few stocks for investors to consider.
Via
Benzinga
Why Is Vision Disorder-Focused EyePoint Pharmaceuticals Stock Trading Higher Today?
November 01, 2023
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) reported Q3 revenues of $15.20 million, up from $10 million a year ago and beating
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 28, 2023
Via
Benzinga
Why Shares of EyePoint Pharmaceuticals Were Rising Monday
September 11, 2023
The company reported positive trial data for its lead therapy to treat two different eye conditions.
Via
The Motley Fool
Why's Going On With EyePoint Pharmaceuticals Stock Today?
September 11, 2023
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) announced interim masked safety data for its lead product candidate EYP-1901 from its ongoing Phase 2 PAVIA trial of EYP-1901 as a potential nine-month...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 05, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 13, 2023
Via
Benzinga
Why Are EyePoint Pharmaceuticals Shares Trading Higher Today
July 10, 2023
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) shares are trading higher after the company appointed Jay Duker as chief executive officer, transitioning from his most recent role as chief operating
Via
Benzinga
EyePoint's EYP-1901 Tipped to Transform Wet AMD Market, Analyst Predicts Potential $870M Sales by 2035
June 14, 2023
JonesResearch has initiated coverage of ophthalmic biopharmaceutical company EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) with a Buy rating and
Via
Benzinga
Why Is Alimera Sciences (ALIM) Stock Up 21% Today?
May 18, 2023
Alimera Sciences (ALIM) stock is taking off on Thursday after signing a major deal with EyePoint Pharmaceuticals (EYPT).
Via
InvestorPlace
EyePoint Pharma Offloads Its Commercially-Available Eye Implant For $82.5M Plus Royalties
May 18, 2023
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) has agreed to sell Yutiq (fluocinolone acetonide intravitreal implant) 0.18mg to Alimera Sciences Inc (NASDAQ: ALIM).
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023
June 14, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.